Mankind Pharma Limited IPO

MANKIND IPO

Mankind Pharma Limited Incorporated in 1991, Company develops, manufactures, and markets pharmaceutical formulations across various acute and chronic therapeutic areas and several consumer healthcare products.

In India, the business is active in a number of acute and chronic therapeutic fields, including anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins/minerals/nutrients, and respiratory.

Mankind Pharma Limited IPO Timetable

ParticularDate
IPO Open Date25 Apr 2023
IPO Close Date27 Apr 2023
Allotment Date03 May 2023
IPO Listing Date09 May 2023

Mankind Pharma Limited IPO Details

Issue TypeBook Built Issue IPO
Face ValueRs. 1 Per Equity Share
IPO PriceRs. 1026 to Rs. 1080 Per Equity Share
Market Lot13 Share
ISIN Code
Listing AtNSE & BSE
Issue SizeApprox. Rs. 4326 Crore.

Mankind Pharma Limited IPO Lot Size

ApplicationLotsSharesAmount
Minimum113Rs. 14040
Maximum14182Rs. 196560
Small HNI (Minimum)15195Rs. 210600
Big HNI (Minimum)72936Rs. 1010880

Mankind Pharma Limited IPO Details Allotment Status

Click Here To Check IPO Allotment Status Mankind Pharma Limited IPO

Click Here To Get ASBA Forms Mankind Pharma Limited IPO

Company Financials:

Particular31 March 202231 March 202131 March 2020
Total Assets9147.776372.635073.29
Total Revenue7977.586385.385975.65
Profit After Tax1452.961293.031056.15
for accurate figures follow the company financials.

Company Promoters:

Ramesh Juneja, Rajeev Juneja, Sheetal Arora, Ramesh Juneja Family Trust, Rajeev Juneja Family Trust, and Prem Sheetal Family Trust are the company promoters.

Registrar & Company Details

Company Contact InformationIPO Registrar
Mankind Pharma Limited


208, Okhla Industrial Estate
Phase-III,
New Delhi 110020
Phone: +91 11 4684 6700
Email: investors@mankindpharma.com
Website: https://www.mankindpharma.com/
KFin Technologies Limited





Phone: 04067162222, 04079611000
Email: mankind.ipo@kfintech.com
Website: https://karisma.kfintech.com

Related posts

Leave a Comment